Fluidic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

Fairfield Market Research, a leading provider of market intelligence, unveils its latest report on the Fluidic Devices market, forecasting robust growth in the industry. In 2024, the global fluidic devices market attained an impressive size of US$ 280 million. The market is projected to witness a substantial growth, surging to US$ 600 million by the close of 2031.

Exploring Fluidic Devices: A Foundation for Scientific Advancement

Fluidics, a versatile field of study, encompasses a wide range of scientific applications, utilizing devices with microliter volumes or micrometer dimensions. These devices are crafted from diverse materials, influencing the flow, absorptivity, biocompatibility, and functionality of fluidic components.

Empowering Point-of-Care Diagnostics

Fluidic devices play a pivotal role in advancing point-of-care diagnostics by offering miniaturized, portable, and user-friendly platforms for conducting a variety of diagnostic tests. By eliminating the need to send samples to centralized laboratories, point-of-care diagnostics reduce turnaround time for test results, proving efficient in resource-limited or remote settings. Microfluidic devices serve as the backbone of these on-site testing solutions.

Enhancing Healthcare Through Early Detection and Monitoring

Integrated fluidic devices are instrumental in monitoring health parameters such as glucose levels, cholesterol, infectious diseases, and biomarkers. They enable early detection, continuous monitoring of chronic conditions, and preventive healthcare interventions. Timely diagnosis and early intervention are vital for improving patient outcomes, aiding healthcare professionals in informed treatment decisions and elevating patient care.

National Institutes of Health (NIH) Advancement: In 2022, NIH showcased the transformative impact of Artificial Intelligence (AI) on fluidic devices used in point-of-care clinical diagnostics. This innovation has paved the way for cost-effective polymer devices. An AI-controlled platform driven by an Android smartphone achieved real-time ELISA detection of the Human Cardiac Troponin I biomarker, with a detection limit of 0.98 pg/mL. This AI-driven revolution in fluidics holds immense promise.

Applications Beyond Boundaries

Portable fluidic devices empower point-of-care diagnostics, offering miniaturized platforms for immediate test results, enabling swift diagnosis, and facilitating prompt treatment decisions. Researchers have reported the growing adoption of fluidic device innovations in detecting and treating a spectrum of malignancies in various vital organs, including the brain, lungs, heart, kidneys, gut, and skin.

Microfluidics and Nanofluidics Publication 2021: Researchers are actively developing a brain-on-a-chip (BoC) system, a miniaturized engineered platform, aiming to assess physiological data. This advancement holds promise for neuroscientists as it facilitates the study of axon properties, drug activity assessment, and examination of axonal regrowth following axotomy.

Why Fluidic Devices Thrive in the Life Sciences Industry?

"Data Precision & Accuracy in Point-of-care Diagnostics"

In the life sciences industry, the demand for precise and reliable data in diagnostics, drug discovery, and research has surged. Fluidic devices offer precise control over fluid flow, reaction conditions, and sample manipulation, ensuring reproducibility and reliability. Technological advances, including smart sensors, automation, and connectivity features, hold immense potential for real-time monitoring.

Nature Journal Article 2023: An article highlights the significance of fluidic technology, transforming mobile health platforms for early patient screening by integrating optical sensing and artificial intelligence analysis.

Early detection and personalized medicine fuel the medical diagnostics market, with fluidic devices meeting the escalating demand for faster, more accurate, and cost-effective solutions. Their ability to work with small sample quantities and perform multiplexed analysis aligns with the trend toward specialized and efficient screening and diagnostic methods.

Challenges Hindering Fluidic Device Adoption

"Lack of Interoperability and Limited Access to Venture Capital"

The lack of interoperability between microfluidic devices and existing laboratory equipment poses a significant challenge to integrating microfluidics into established workflows and adopting them for routine drug screening and discovery processes. While fluidic approaches offer advantages, careful consideration of existing macroscopic approaches is essential.

Despite promising theoretical models and studies, only a limited number of lab-on-a-chip (LOC) systems are commercialized due to challenges in fabrication technology, manufacturing processes, and standardized practices. Standardization, improved fabrication techniques, and fault mode understanding are necessary to overcome these barriers.

Access to venture capital is vital for the growth of fluidic device start-ups, supporting early-stage development, innovation, talent acquisition, and product commercialization. Insufficient funding limits resources for research and development, manufacturing capabilities, marketing, and scaling operations.

Country-wise Insights

United States Market: The U.S. market benefits from a well-established healthcare infrastructure and significant investments in microfluidic device production, giving firms a competitive advantage for global expansion.

Germany Market: Germany's market is expanding due to outpatient research focused on diagnostic precision in point-of-care devices and favorable healthcare policies that support medical technology.

Opportunities in China: China presents opportunities driven by a high prevalence of chronic diseases, increasing healthcare expenditure, and a growing demand for point-of-care diagnosis, particularly for conditions like diabetes, cancer, and cardiovascular disorders.

Competitive Landscape

The fluidic devices market is highly competitive, with both established players and new entrants contributing to its dynamism.

Key Companies Covered:

Cellix Ltd.
Elveflow
Nortis Inc.
Fluigent SA
Perkinelmer, Inc.
Fluidic Analytics
Blacktrace Holdings Ltd. (Dolomite Microfluidics)
SynVivo, Inc.
Emulatebio
Micronit B.V.
Emerson Electric Co.
LUMICKS
microfluidic ChipShop GmbH
Bartels Mikrotechnik GmbH
LEE Ventus
CETONI GmbH
Christian Burkert GmbH & Co. KG
VWR International, LLC
Harvard Apparatus

Key Segments of Fluidic Devices Industry Research

Product:

Microchips

Polymers

Glass

Silicon

Ceramics

Others

Flow & Pressure Sensors
Flow & Pressure Controllers
Microfluidic Valves
Micropumps/Microinjectors

Syringe Microinjectors/Micropumps

Peristaltic Pumps

Pressure Microinjectors/Micropumps

Others

Microfluidic-based-Devices

Organ-on-Chip

TEER-on-Chip

Other Components

Application:

Disease Diagnostics

Clinical Diagnostics

Point-of-Care Testing

Pharma & Life Science Research & Manufacturing

Genomics

Proteomics

Drug Discovery & Development

Capillary Electrophoresis

Others (Micro Reactions, Microdispensing, etc.)

Others (Forensics, Environmental, Food Safety, and Quality Control)

End User:

Hospitals
Diagnostic Centers
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Fluidic Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Fluidic Devices Market Outlook, 2018 - 2031

3.1. Global Fluidic Devices Market Outlook, by Material, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Polymer
    - 3.1.1.1.1. Polyvinyl Chloride (PVC)
    - 3.1.1.1.2. Non-polyvinyl Chloride
  - 3.1.1.2. Glass
  - 3.1.1.3. Silicon
  - 3.1.1.4. Metal
  - 3.1.1.5. Ceramics
3.2. Global Fluidic Devices Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Point of care testing
  - 3.2.1.2. Clinical Diagnostics
  - 3.2.1.3. Drug Delivery
  - 3.2.1.4. Analytical Testing
    - 3.2.1.4.1. Genomics
    - 3.2.1.4.2. Proteomics
    - 3.2.1.4.3. Cell based Analysis
    - 3.2.1.4.4. Others
3.3. Global Fluidic Devices Market Outlook, by Industry, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Pharmaceuticals
  - 3.3.1.2. In-vitro Diagnostics
  - 3.3.1.3. Environmental Research
  - 3.3.1.4. Life Science Research
  - 3.3.1.5. Clinical Diagnostics
3.4. Global Fluidic Devices Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Fluidic Devices Market Outlook, 2018 - 2031

4.1. North America Fluidic Devices Market Outlook, by Material, Value (US$ Mn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Polymer
    - 4.1.1.1.1. Polyvinyl Chloride (PVC)
    - 4.1.1.1.2. Non-polyvinyl Chloride
  - 4.1.1.2. Glass
  - 4.1.1.3. Silicon
  - 4.1.1.4. Metal
  - 4.1.1.5. Ceramics
4.2. North America Fluidic Devices Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Point of care testing
  - 4.2.1.2. Clinical Diagnostics
  - 4.2.1.3. Drug Delivery
  - 4.2.1.4. Analytical Testing
    - 4.2.1.4.1. Genomics
    - 4.2.1.4.2. Proteomics
    - 4.2.1.4.3. Cell based Analysis
    - 4.2.1.4.4. Others
4.3. North America Fluidic Devices Market Outlook, by Industry, Value (US$ Mn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Pharmaceuticals
  - 4.3.1.2. In-vitro Diagnostics
  - 4.3.1.3. Environmental Research
  - 4.3.1.4. Life Science Research
  - 4.3.1.5. Clinical Diagnostics
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Fluidic Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 4.4.1.2. U.S. Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 4.4.1.3. U.S. Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 4.4.1.4. Canada Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 4.4.1.5. Canada Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 4.4.1.6. Canada Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Fluidic Devices Market Outlook, 2018 - 2031

5.1. Europe Fluidic Devices Market Outlook, by Material, Value (US$ Mn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Polymer
    - 5.1.1.1.1. Polyvinyl Chloride (PVC)
    - 5.1.1.1.2. Non-polyvinyl Chloride
  - 5.1.1.2. Glass
  - 5.1.1.3. Silicon
  - 5.1.1.4. Metal
  - 5.1.1.5. Ceramics
5.2. Europe Fluidic Devices Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Point of care testing
  - 5.2.1.2. Clinical Diagnostics
  - 5.2.1.3. Drug Delivery
  - 5.2.1.4. Analytical Testing
    - 5.2.1.4.1. Genomics
    - 5.2.1.4.2. Proteomics
    - 5.2.1.4.3. Cell based Analysis
    - 5.2.1.4.4. Others
5.3. Europe Fluidic Devices Market Outlook, by Industry, Value (US$ Mn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Pharmaceuticals
  - 5.3.1.2. In-vitro Diagnostics
  - 5.3.1.3. Environmental Research
  - 5.3.1.4. Life Science Research
  - 5.3.1.5. Clinical Diagnostics
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Fluidic Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 5.4.1.2. Germany Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.4.1.3. Germany Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 5.4.1.4. U.K. Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 5.4.1.5. U.K. Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.4.1.6. U.K. Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 5.4.1.7. France Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 5.4.1.8. France Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.4.1.9. France Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 5.4.1.10. Italy Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 5.4.1.11. Italy Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.4.1.12. Italy Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 5.4.1.13. Turkey Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 5.4.1.14. Turkey Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.4.1.15. Turkey Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 5.4.1.16. Russia Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 5.4.1.17. Russia Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.4.1.18. Russia Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 5.4.1.19. Rest of Europe Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 5.4.1.20. Rest of Europe Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.4.1.21. Rest of Europe Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Fluidic Devices Market Outlook, 2018 - 2031

6.1. Asia Pacific Fluidic Devices Market Outlook, by Material, Value (US$ Mn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Polymer
    - 6.1.1.1.1. Polyvinyl Chloride (PVC)
    - 6.1.1.1.2. Non-polyvinyl Chloride
  - 6.1.1.2. Glass
  - 6.1.1.3. Silicon
  - 6.1.1.4. Metal
  - 6.1.1.5. Ceramics
6.2. Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Point of care testing
  - 6.2.1.2. Clinical Diagnostics
  - 6.2.1.3. Drug Delivery
  - 6.2.1.4. Analytical Testing
    - 6.2.1.4.1. Genomics
    - 6.2.1.4.2. Proteomics
    - 6.2.1.4.3. Cell based Analysis
    - 6.2.1.4.4. Others
6.3. Asia Pacific Fluidic Devices Market Outlook, by Industry, Value (US$ Mn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Pharmaceuticals
  - 6.3.1.2. In-vitro Diagnostics
  - 6.3.1.3. Environmental Research
  - 6.3.1.4. Life Science Research
  - 6.3.1.5. Clinical Diagnostics
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Fluidic Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 6.4.1.2. China Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.4.1.3. China Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 6.4.1.4. Japan Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 6.4.1.5. Japan Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.4.1.6. Japan Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 6.4.1.7. South Korea Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 6.4.1.8. South Korea Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.4.1.9. South Korea Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 6.4.1.10. India Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 6.4.1.11. India Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.4.1.12. India Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 6.4.1.13. Southeast Asia Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 6.4.1.14. Southeast Asia Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.4.1.15. Southeast Asia Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Fluidic Devices Market Outlook, 2018 - 2031

7.1. Latin America Fluidic Devices Market Outlook, by Material, Value (US$ Mn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Polymer
    - 7.1.1.1.1. Polyvinyl Chloride (PVC)
    - 7.1.1.1.2. Non-polyvinyl Chloride
  - 7.1.1.2. Glass
  - 7.1.1.3. Silicon
  - 7.1.1.4. Metal
  - 7.1.1.5. Ceramics
7.2. Latin America Fluidic Devices Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
7.3. Latin America Fluidic Devices Market Outlook, by Industry, Value (US$ Mn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Pharmaceuticals
  - 7.3.1.2. In-vitro Diagnostics
  - 7.3.1.3. Environmental Research
  - 7.3.1.4. Life Science Research
  - 7.3.1.5. Clinical Diagnostics
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Fluidic Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 7.4.1.2. Brazil Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.4.1.3. Brazil Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 7.4.1.4. Mexico Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 7.4.1.5. Mexico Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.4.1.6. Mexico Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 7.4.1.7. Argentina Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 7.4.1.8. Argentina Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.4.1.9. Argentina Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Fluidic Devices Market Outlook, 2018 - 2031

8.1. Middle East & Africa Fluidic Devices Market Outlook, by Material, Value (US$ Mn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Polymer
    - 8.1.1.1.1. Polyvinyl Chloride (PVC)
    - 8.1.1.1.2. Non-polyvinyl Chloride
  - 8.1.1.2. Glass
  - 8.1.1.3. Silicon
  - 8.1.1.4. Metal
  - 8.1.1.5. Ceramics
8.2. Middle East & Africa Fluidic Devices Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Point of care testing
  - 8.2.1.2. Clinical Diagnostics
  - 8.2.1.3. Drug Delivery
  - 8.2.1.4. Analytical Testing
    - 8.2.1.4.1. Genomics
    - 8.2.1.4.2. Proteomics
    - 8.2.1.4.3. Cell based Analysis
    - 8.2.1.4.4. Others
8.3. Middle East & Africa Fluidic Devices Market Outlook, by Industry, Value (US$ Mn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Pharmaceuticals
  - 8.3.1.2. In-vitro Diagnostics
  - 8.3.1.3. Environmental Research
  - 8.3.1.4. Life Science Research
  - 8.3.1.5. Clinical Diagnostics
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Fluidic Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 8.4.1.2. GCC Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.4.1.3. GCC Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 8.4.1.4. South Africa Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 8.4.1.5. South Africa Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.4.1.6. South Africa Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 8.4.1.7. Egypt Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 8.4.1.8. Egypt Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.4.1.9. Egypt Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 8.4.1.10. Nigeria Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 8.4.1.11. Nigeria Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.4.1.12. Nigeria Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Fluidic Devices Market by Material, Value (US$ Mn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Fluidic Devices Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Fluidic Devices Market by Industry, Value (US$ Mn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Industry vs by Application Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Agilent Technologies
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. PerkinElmer Inc.
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Thermo Fisher Scientific Inc.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Qiagen NV
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Bio-Rad Laboratories, Inc.
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Fluidigm Corporation
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Abbott Laboratories
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. F. Hoffmann-La Roche Ltd
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Horizon Microtechnologies
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations